Therefore, more substantial evidence regarding the efficacy of combining radiotherapy and EGFR‐TKIs for patients with NSCLC and EGFR mutation could be forthcoming from various current prospective trials, including NCT02788058, NCT00973310, NCT03727867, and NCT02893332. This evidence concerns the gene EGFR and non-small cell lung carcinoma.